Converting enzyme inhibition resets cerebral autoregulation at lower blood pressure.

The cerebrovascular effect of converting enzyme inhibition was investigated in normal volunteers, in hypertensive patients and in patients with severe chronic heart failure. Cerebral blood flow (CBF) was measured by single photon emission tomography of the uptake and wash-out of inhaled xenon-133. In some of the patients, CBF was also monitored by repeated determinations of the cerebral arterio-venous oxygen difference. In the normal volunteers and the hypertensive patients captopril (50 mg) caused a downward shift of the lower limit of CBF autoregulation of 10-15 mmHg. In some of the patients with chronic heart failure, captopril (6.25 mg) induced a marked decrease of the arterial blood pressure. Regional and average CBF, however, remained constant. These findings indicate that captopril treatment may protect the brain against ischaemia during sudden decreases of the blood pressure by a shift of the lower limit of CBF autoregulation.
AuthorsO B Paulson, S Vorstrup, A R Andersen, J Smith, J Godtfredsen
JournalJournal of hypertension. Supplement : official journal of the International Society of Hypertension (J Hypertens Suppl) Vol. 3 Issue 3 Pg. S487-8 (Dec 1985) ISSN: 0952-1178 [Print] ENGLAND
PMID2856774 (Publication Type: Journal Article)
Chemical References
  • Angiotensin-Converting Enzyme Inhibitors
  • Captopril
  • Angiotensin-Converting Enzyme Inhibitors (adverse effects, pharmacology, therapeutic use)
  • Blood Pressure (drug effects, physiology)
  • Captopril (adverse effects, pharmacology, therapeutic use)
  • Cerebrovascular Circulation (drug effects)
  • Homeostasis (drug effects)
  • Humans
  • Tomography, Emission-Computed, Single-Photon

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: